查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941148

腫瘤資訊系統市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品/服務、應用、最終用戶、地區和競爭格局分類），2021-2031年

Oncology Information System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球腫瘤資訊系統市場預計將從 2025 年的 98.6 億美元成長到 2031 年的 154.6 億美元，複合年成長率為 7.78%。

這些專業軟體平台旨在全面管理與癌症治療相關的整體臨床、行政和財務數據，從而實現腫瘤內科和放射腫瘤科之間的無縫工作流程。市場的主要促進因素包括迫切需要整合分散的病患記錄，以及電子健康記錄的日益普及，以促進精準的治療計畫。因此，面對日益加重的全球疾病負擔，這些系統對於最大限度地提高臨床效率和確保符合實證醫學標準至關重要。

市場概覽
預測期 2027-2031
市場規模：2025年 98.6億美元
市場規模：2031年 154.6億美元
複合年成長率：2026-2031年 7.78%
成長最快的細分市場 專業服務
最大的市場 北美洲

然而，實施這些系統的高昂成本對市場成長構成重大障礙，尤其對於那些難以承擔巨額初始投資的小規模醫療中心而言更是如此。此外，各種數位系統之間缺乏互通性也常常阻礙必要的醫療數據共用。這類綜合管理解決方案的需求源自於癌症發生率的不斷上升。美國癌症協會預測，到2025年，美國將新增約2,041,910例癌症病例，凸顯了醫療服務提供者必須有效處理大量病患資訊的重要性。

市場促進因素

人工智慧 (AI) 和機器學習在治療計劃中的應用正對全球腫瘤資訊系統市場產生變革性影響，顯著改變臨床操作和決策策略。這些先進的演算法工具正逐步整合到腫瘤系統中，以實現器官分割和劑量最佳化等複雜流程的自動化，從而提高準確性並減輕臨床團隊的行政負擔。隨著醫療機構尋求應對日益複雜的癌症管理，這些智慧輔助系統的應用正在加速發展。 OncLive 在 2025 年 1 月發表的一篇題為《調查結果：人工智慧不會退出腫瘤領域，但其有效性仍令人擔憂》的報導中強調了這一轉變。報導指出，26.7% 的受訪腫瘤科醫師目前使用人工智慧工具輔助治療決策，顯示自動化輔助已成為顯著趨勢。

同時，政府對癌症研究的支持和投入不斷增加，為實施這些先進的數位基礎設施奠定了必要的財政基礎。公共部門的投資對於醫療設施現代化、集中管理患者記錄以及實施符合價值醫療策略的整合系統至關重要。這項承諾也體現在近期的政策措施中。例如，英國政府在2025年5月於GOV.UK網站發布的題為「政府技術改革助力癌症診斷轉型」的新聞稿中承諾設立10億英鎊的專款，用於數位轉型。這項財政支持不僅加速了系統的應用，也刺激了市場動態。這一趨勢同樣體現在私部門。西門子醫療在2024年11月發布的「2024年第四季財務表現」中預測，其2025年的銷售額將年增5-6%。這主要得益於市場對尖端腫瘤技術的持續需求。

市場挑戰

高昂的實施成本是全球腫瘤資訊系統市場擴張的主要障礙。實施一套全面的腫瘤平台需要大量的資本支出，包括軟體採購、硬體整合和專業人員培訓，這構成了很高的進入門檻。對於不具備大規模學術醫療中心雄厚資源的中小型醫療機構和私人診所而言，這種財務負擔尤其沉重。因此，這些小規模的機構往往會延後採用必要的數位化管理工具，這直接抑制了整體市場需求，並減緩了整個產業的技術普及。

不斷上漲的營運成本與停滯不前的報銷率之間的巨大差距，進一步加劇了這些財務困境。根據美國醫院協會 (AHA) 2025 年的數據，2022 年至 2024 年間，整體通貨膨脹率上漲了 14.1%，而聯邦醫療保險 (Medicare) 的住院支付率僅上漲了 5.1%。這種經濟差距嚴重限制了醫療服務提供者可支配的財務資源。面對利潤率的下降，各機構被迫優先考慮眼前的患者照護成本，而非投資新的IT基礎設施，阻礙了腫瘤資訊系統市場的整體成長。

市場趨勢

雲端和SaaS腫瘤資訊系統（OIS）平台的廣泛應用正在改變癌症診療模式，以靈活的Web架構取代了傳統的本地伺服器。這些創新使多學科團隊能夠隨時隨地安全地存取關鍵的患者資訊和治療方案，支援複雜腫瘤會診所需的遠端協作，同時顯著降低本地硬體維護成本。這種向靈活軟體環境的轉變是市場活動的關鍵促進因素。例如，RaySearch Laboratories在其2025年11月發布的「2025會計年度第三季中期報告」中指出，其淨銷售額年增13%至3.32億瑞典克朗，並將這一成長主要歸功於市場對其腫瘤資訊系統和規劃軟體RayCare的強勁需求。

將基因組數據整合到精準腫瘤學工作流程中，正迫使腫瘤免疫系統（OIS）提供者更新其系統，以便在標準臨床記錄之外管理複雜的分子圖譜。隨著治療越來越側重於基因突變，腫瘤平台必須能夠直接導入、儲存和顯示次世代定序數據，以支持治療決策。這項功能使臨床醫生無需離開其主要工作區，即可有效地將具有特定生物標記的患者與合適的免疫療法進行配對。 Guardant Health 在 2025 年 12 月發布的題為「Guardant Health 宣布與 Trial Library 合作」的新聞稿中揭示了這種數據利用的規模。該公司透露，它正在利用大規模真實世界數據平台，以增強對合格精準醫療試驗條件的候選人的識別。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球腫瘤資訊系統市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品/服務（軟體、專業服務）分類
    • 依應用領域（放射腫瘤學、內科腫瘤學、外科腫瘤學）
    • 依最終使用者（醫院/腫瘤診所、研究中心、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美腫瘤資訊系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲腫瘤資訊系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區腫瘤資訊系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲腫瘤資訊系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲腫瘤資訊系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球腫瘤資訊系統市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Elekta AB
  • Varian Medical Systems, Inc.
  • Epic Systems Corporation
  • Philips Healthcare
  • Cerner Corporation
  • IBM Corporation
  • Siemens Healthineers
  • RaySearch Laboratories AB
  • Koninklijke Philips NV
  • McKesson Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19583

The Global Oncology Information System Market is anticipated to expand from USD 9.86 Billion in 2025 to USD 15.46 Billion by 2031, reflecting a compound annual growth rate of 7.78%. These specialized software platforms are engineered to oversee the full spectrum of clinical, administrative, and financial data related to cancer treatment, enabling seamless workflows across medical and radiation oncology. Key market drivers include the urgent need to consolidate scattered patient records and the growing incorporation of electronic medical records to facilitate accurate treatment planning. Consequently, these systems are vital for maximizing clinical productivity and ensuring compliance with evidence-based standards in the face of an increasing global disease burden.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 9.86 Billion
Market Size 2031USD 15.46 Billion
CAGR 2026-20317.78%
Fastest Growing SegmentProfessional Service
Largest MarketNorth America

However, the high expense associated with deploying these systems poses a major obstacle to market growth, especially for smaller healthcare centers that cannot easily afford the substantial upfront capital required. Furthermore, the lack of interoperability among various digital systems frequently hinders the necessary sharing of medical data. The demand for these comprehensive management solutions is driven by the rising prevalence of cancer; the American Cancer Society projects that there will be approximately 2,041,910 new cancer cases in the United States in 2025, emphasizing the massive volume of patient information that healthcare providers must efficiently handle.

Market Driver

The incorporation of Artificial Intelligence and Machine Learning into treatment planning is emerging as a revolutionary influence in the Global Oncology Information System Market, significantly altering clinical operations and decision-making strategies. These sophisticated algorithmic tools are progressively being integrated into oncology systems to automate intricate processes like organ segmentation and dose optimization, which improves accuracy and lessens the administrative load on clinical teams. As providers attempt to handle the increasing intricacies of cancer management, the uptake of these smart support systems is gaining momentum. This shift is highlighted by data from OncLive in January 2025, which reported in an article titled 'Survey Says: AI Isn't Going Anywhere in Oncology, But Validity Concerns Remain' that 26.7% of surveyed oncologists are now using AI tools for treatment decision support, signaling a major move towards automated assistance.

Simultaneously, rising government support and funding for cancer research are establishing the necessary financial foundation for implementing these advanced digital infrastructures. Public sector investments are essential for updating healthcare facilities, enabling them to acquire integrated systems that centralize patient records and align with value-based care strategies. This dedication is visible in recent policy actions; for instance, the UK government confirmed a £1 billion fund dedicated to digital transformation in a press release titled 'Government's tech reform to transform cancer diagnosis' published on GOV.UK in May 2025. This financial backing not only aids in system adoption but also boosts market dynamics, a trend mirrored in the private sector where Siemens Healthineers, in their 'Q4 Fiscal Year 2024 Financial Results' from November 2024, anticipated comparable revenue growth of 5% to 6% for fiscal year 2025, largely attributed to the ongoing demand for cutting-edge oncology technologies.

Market Challenge

The significant expense required for implementation serves as a major impediment to the expansion of the Global Oncology Information System Market. Deploying comprehensive oncology platforms necessitates a considerable financial outlay for purchasing software, integrating hardware, and training specialized personnel, which establishes a steep barrier to entry. This financial burden is especially difficult for smaller healthcare institutions and independent practices that do not possess the extensive resources found in large academic centers. Consequently, these smaller organizations frequently delay the acquisition of necessary digital management tools, which directly dampens overall market demand and retards the speed of technological adoption throughout the industry.

These financial limitations are further exacerbated by the gap between escalating operational expenses and stagnant reimbursement rates. Data from the American Hospital Association in 2025 indicates that while general inflation surged by 14.1 percent between 2022 and 2024, Medicare inpatient payment rates saw a mere 5.1 percent increase. This economic disparity severely limits the discretionary funds available to healthcare providers. Faced with shrinking margins, organizations are forced to prioritize immediate patient care costs over investments in new IT infrastructure, thereby hindering the broader growth of the oncology information system market.

Market Trends

The broad acceptance of Cloud-Based and SaaS OIS platforms is transforming cancer care by substituting rigid on-premise servers with adaptable, web-enabled architectures. These innovations enable multidisciplinary teams to securely access vital patient information and treatment strategies from any location, supporting the remote collaboration necessary for complex tumor boards while substantially lowering costs associated with local hardware maintenance. This transition towards flexible software environments is a primary driver of market activity; for example, RaySearch Laboratories reported a 13% increase in net sales to SEK 332 million in their 'Interim report third quarter 2025' from November 2025, a growth largely attributed to strong demand for their RayCare oncology information system and planning software.

The integration of genomic data into precision oncology workflows is forcing OIS providers to update their systems to manage intricate molecular profiles alongside standard clinical records. As treatments become increasingly tailored to genetic mutations, oncology platforms are required to ingest, store, and display next-generation sequencing data to directly aid therapeutic decision-making. This capability ensures that clinicians can efficiently match patients exhibiting specific biomarkers with the correct immunotherapies without exiting their primary workspace. The magnitude of this data usage is illustrated by Guardant Health, which, in a December 2025 press release titled 'Guardant Health Announces Collaboration with Trial Library', revealed that it utilizes a vast real-world data platform containing over 1 million tested patients to enhance the identification of suitable candidates for precision medicine trials.

Key Market Players

  • Elekta AB
  • Varian Medical Systems, Inc.
  • Epic Systems Corporation
  • Philips Healthcare
  • Cerner Corporation
  • IBM Corporation
  • Siemens Healthineers
  • RaySearch Laboratories AB
  • Koninklijke Philips N.V.
  • McKesson Corporation

Report Scope

In this report, the Global Oncology Information System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oncology Information System Market, By Product & Services

  • Software
  • Professional Service

Oncology Information System Market, By Application

  • Radiation Oncology
  • Medical Oncology
  • Surgical Oncology

Oncology Information System Market, By End User

  • Hospital & Oncology Clinic
  • Research Center
  • Others

Oncology Information System Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oncology Information System Market.

Available Customizations:

Global Oncology Information System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oncology Information System Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product & Services (Software, Professional Service)
    • 5.2.2. By Application (Radiation Oncology, Medical Oncology, Surgical Oncology)
    • 5.2.3. By End User (Hospital & Oncology Clinic, Research Center, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Oncology Information System Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product & Services
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Oncology Information System Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product & Services
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Oncology Information System Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product & Services
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Oncology Information System Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product & Services
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Oncology Information System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product & Services
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Oncology Information System Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product & Services
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Oncology Information System Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product & Services
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Oncology Information System Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product & Services
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Oncology Information System Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product & Services
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Oncology Information System Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product & Services
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Oncology Information System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product & Services
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Oncology Information System Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product & Services
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Oncology Information System Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product & Services
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Oncology Information System Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product & Services
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Oncology Information System Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product & Services
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Oncology Information System Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product & Services
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Oncology Information System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product & Services
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Oncology Information System Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product & Services
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Oncology Information System Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product & Services
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Oncology Information System Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product & Services
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Oncology Information System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product & Services
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Oncology Information System Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product & Services
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Oncology Information System Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product & Services
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Oncology Information System Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product & Services
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Oncology Information System Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Elekta AB
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Varian Medical Systems, Inc.
  • 15.3. Epic Systems Corporation
  • 15.4. Philips Healthcare
  • 15.5. Cerner Corporation
  • 15.6. IBM Corporation
  • 15.7. Siemens Healthineers
  • 15.8. RaySearch Laboratories AB
  • 15.9. Koninklijke Philips N.V.
  • 15.10. McKesson Corporation

16. Strategic Recommendations

17. About Us & Disclaimer